Page last updated: 2024-08-16

troglitazone and 4-nitroquinoline-1-oxide

troglitazone has been researched along with 4-nitroquinoline-1-oxide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirose, Y; Katayama, M; Kohno, H; Kuno, T; Mori, H; Qiao, Z; Sakata, K; Shibata, T; Sugie, S; Tanaka, T; Yamada, Y; Yoshida, K1

Other Studies

1 other study(ies) available for troglitazone and 4-nitroquinoline-1-oxide

ArticleYear
Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide.
    Cancer science, 2003, Volume: 94, Issue:4

    Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogens; Chromans; Cyclin D1; Cyclooxygenase 2; DNA-Binding Proteins; Incidence; Isoenzymes; Ligands; Male; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Tongue; Tongue Neoplasms; Transcription Factors; Troglitazone; Tumor Cells, Cultured

2003